SE0302924D0 - Pharmaceutical composition having a cationic excipient - Google Patents

Pharmaceutical composition having a cationic excipient

Info

Publication number
SE0302924D0
SE0302924D0 SE0302924A SE0302924A SE0302924D0 SE 0302924 D0 SE0302924 D0 SE 0302924D0 SE 0302924 A SE0302924 A SE 0302924A SE 0302924 A SE0302924 A SE 0302924A SE 0302924 D0 SE0302924 D0 SE 0302924D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
cationic excipient
excipient
cationic
betaine
Prior art date
Application number
SE0302924A
Other languages
English (en)
Inventor
Helena Ljusberg-Wahren
Dan Lundberg
Krister Holmberg
Original Assignee
Camurus Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Camurus Ab filed Critical Camurus Ab
Priority to SE0302924A priority Critical patent/SE0302924D0/sv
Publication of SE0302924D0 publication Critical patent/SE0302924D0/sv
Priority to US10/577,836 priority patent/US20070031485A1/en
Priority to AT04793869T priority patent/ATE400256T1/de
Priority to PCT/SE2004/001569 priority patent/WO2005044237A1/en
Priority to EP04793869A priority patent/EP1684730B1/en
Priority to DE602004014964T priority patent/DE602004014964D1/de
Priority to US13/895,064 priority patent/US20130267585A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
SE0302924A 2003-11-05 2003-11-05 Pharmaceutical composition having a cationic excipient SE0302924D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE0302924A SE0302924D0 (sv) 2003-11-05 2003-11-05 Pharmaceutical composition having a cationic excipient
US10/577,836 US20070031485A1 (en) 2003-11-05 2004-10-29 Pharmaceutical composition having a cationic excipient
AT04793869T ATE400256T1 (de) 2003-11-05 2004-10-29 Pharmazeutische zusammensetzung mit einem kationischen hilfsmittel
PCT/SE2004/001569 WO2005044237A1 (en) 2003-11-05 2004-10-29 Pharmaceutical composition having a cationic excipient
EP04793869A EP1684730B1 (en) 2003-11-05 2004-10-29 Pharmaceutical composition having a cationic excipient
DE602004014964T DE602004014964D1 (de) 2003-11-05 2004-10-29 Pharmazeutische zusammensetzung mit einem kationischen hilfsmittel
US13/895,064 US20130267585A1 (en) 2003-11-05 2013-05-15 Pharmaceutical composition having a cationic excipient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302924A SE0302924D0 (sv) 2003-11-05 2003-11-05 Pharmaceutical composition having a cationic excipient

Publications (1)

Publication Number Publication Date
SE0302924D0 true SE0302924D0 (sv) 2003-11-05

Family

ID=29707847

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0302924A SE0302924D0 (sv) 2003-11-05 2003-11-05 Pharmaceutical composition having a cationic excipient

Country Status (6)

Country Link
US (2) US20070031485A1 (sv)
EP (1) EP1684730B1 (sv)
AT (1) ATE400256T1 (sv)
DE (1) DE602004014964D1 (sv)
SE (1) SE0302924D0 (sv)
WO (1) WO2005044237A1 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101691335B (zh) * 2009-10-26 2013-03-27 大庆市富杰化工有限公司 羧酸高碳醇酯基三甲基氯化铵及在粘土稳定剂中的应用
US9889222B2 (en) 2011-11-09 2018-02-13 Kimberly-Clark Worldwide, Inc. Aqueous medium-sensitive coating compositions for triggered release of active ingredients and visual indication for wetness
US8791045B2 (en) 2011-11-09 2014-07-29 Kimberly-Clark Worldwide, Inc. Non-tacky wetness indicator composition for application on a polymeric substrate
US9585826B2 (en) 2012-11-07 2017-03-07 Kimberly-Clark Worldwide, Inc. Triggerable compositions for two-stage, controlled release of active chemistry
US9119780B2 (en) 2013-10-30 2015-09-01 Kimberly-Clark Worldwide, Inc. Triggerable compositions for two-stage, controlled release of proactive chemistry
WO2017192921A1 (en) 2016-05-05 2017-11-09 Monosol Rx, Llc Enhanced delivery epinephrine compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
IL273477B1 (en) * 2017-09-26 2024-04-01 Aquestive Therapeutics Inc Administration of pharmaceutical preparations including penetration enhancers

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE466134B (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner
US5389676A (en) * 1991-03-22 1995-02-14 E. B. Michaels Research Associates, Inc. Viscous surfactant emulsion compositions
IL101241A (en) * 1992-03-16 1997-11-20 Yissum Res Dev Co Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
US5830430A (en) * 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
JPH11504028A (ja) * 1995-04-24 1999-04-06 イースム リサーチ ディベロップメント カンパニー オブ ザ ヒーブル ユニバーシティ オブ エルサレム 油／水エマルジョンを作り出す自己乳化性配合物
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6881420B2 (en) * 2000-06-23 2005-04-19 Teva Pharmaceutical Industries Ltd. Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation
CN1638718A (zh) * 2002-01-31 2005-07-13 克洛达股份有限公司 包括酯类低聚物的添加剂和产品
US20040062778A1 (en) * 2002-09-26 2004-04-01 Adi Shefer Surface dissolution and/or bulk erosion controlled release compositions and devices

Also Published As

Publication number Publication date
US20130267585A1 (en) 2013-10-10
EP1684730A1 (en) 2006-08-02
US20070031485A1 (en) 2007-02-08
DE602004014964D1 (de) 2008-08-21
EP1684730B1 (en) 2008-07-09
ATE400256T1 (de) 2008-07-15
WO2005044237A1 (en) 2005-05-19

Similar Documents

Publication Publication Date Title
AR018109A1 (es) FORMULACIoN GALÉNICA ADMINISTRABLE POR VíA ORAL QUE PERMITE UNA ABSORCIoN MEJORADA DE PRINCIPIOS ACTIVOS, USO DE UN AGENTE MAJORADOR DE ABSORCIoN PARA PREPARAR UNA FORMA DE DOSIFICACIoN ADMINISTRABLE POR VíA ORAL Y PROCEDIMIENTO PARA PREPARAR DICHA FORMULACIoN GALÉNICA
BR0111206A (pt) Derivados de arilmetilamina para uso como inibidores de triptase
BR0107869A (pt) Composições farmacêuticas eletrogiradas
HN2000000267A (es) Oxazolidinonas substituidas y su uso
AR033367A1 (es) Derivados de imidazopirimidina y derivados de triazolopirimidina, un procedimiento para su preparacion, medicamentos, una composicion farmaceutica, y uso de dichos derivados para la preparacion de medicamentos
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
BR0112311A (pt) Compostos e composições para liberar agentes ativos, forma de dosagem unitária, método para preparar ditas composições e seu uso
ECSP066878A (es) [hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa
DE69939180D1 (de) Pharmazeutische zubereitungen zur externen anwendung, die nicht steroidale antiinflammatorische und analgetische wirkstoffe enthalten
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
DE60019334D1 (de) Antivirale arznei
SE9802208D0 (sv) Novel compounds
BRPI0311189B8 (pt) composições farmacêuticas contendo polimorfo a de flibanserin, bem como seu uso
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
BRPI0515555A (pt) composição farmacêutica compreendendo éster de temozolomida
ECSP056186A (es) Composición farmacéutica en forma de hidrogel para administración transdérmica de sustancias activas
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
SE0302924D0 (sv) Pharmaceutical composition having a cationic excipient
AR031679A1 (es) Una composicion farmaceutica
AR048672A1 (es) Tabletas de desintegracion que comprenden licarbazepina
DE60232271D1 (de) Wässrige pharmazeutische formulierungen von wasserlöslichen prodrugs von propofol-verbindungen
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
SE9802209D0 (sv) Novel compounds
SE0000303D0 (sv) Novel compounds
ATE410154T1 (de) Pharmazeutische zusammensetzung enthaltend 2,4- dichlorbenzylalkohol und amylmetakresol